D.R. Horton, Inc. Beats Market Expectations with $10 Billion in Q3 Revenues
D.R. Horton, Inc. reported a 5% increase in net income per diluted share for the third quarter of fiscal 2024, reaching $4.10.
BTC$64,354.00-0.93%
ETH$1,875.11-2.02%
USDT$0.9993+0.02%
USDC$0.9999+0.00%
XRP$1.11-0.37%
SOL$76.11-1.64%
TRX$0.3231-0.31%
FIGR_HELOC$1.04-0.04%
HYPE$64.20-4.62%
DOGE$0.0733-0.39%
USDS$0.9998+0.00%
ZEC$553.68-3.33%
RAIN$0.0139-3.98%
LEO$9.83+0.14%
WBT$56.26-1.04%
BTC$64,354.00-0.93%
ETH$1,875.11-2.02%
USDT$0.9993+0.02%
USDC$0.9999+0.00%
XRP$1.11-0.37%
SOL$76.11-1.64%
TRX$0.3231-0.31%
FIGR_HELOC$1.04-0.04%
HYPE$64.20-4.62%
DOGE$0.0733-0.39%
USDS$0.9998+0.00%
ZEC$553.68-3.33%
RAIN$0.0139-3.98%
LEO$9.83+0.14%
WBT$56.26-1.04%
Abbott Laboratories (NYSE: ABT) reported sales of $10.4 billion in the second quarter of 2024, reflecting a 4.0% increase from the same period last year.
D.R. Horton, Inc. reported a 5% increase in net income per diluted share for the third quarter of fiscal 2024, reaching $4.10.
Johnson & Johnson (NYSE: JNJ) reported a 4.3% increase in sales to $22.4 billion in Q2 2024, with operational growth at 6.6% and adjusted EPS rising…
Elevance Health reported a stable second quarter 2024 performance, with operating revenue slightly decreasing to $43.2 billion.
Morgan Stanley (NYSE: MS) reported a strong Q2 performance in 2024, with net revenues reaching $15.0 billion and earnings per diluted share standing at $1.82.
Bank of America (BAC) reported a robust performance for the second quarter of 2024, with net income reaching $6.9 billion and earnings per diluted share (EPS)…
UnitedHealth Group reported robust financial results for the second quarter of 2024, with revenues reaching $98.9 billion.
Even with beaten EPS estimates in Q2, the macro lag could catch up by the year's end.
Goldman Sachs reported a net revenue of $12.73 billion for Q2 2024.
BlackRock, Inc. reported strong financial results for the second quarter of 2024.
Despite Novo Nordisk's momentum, Eli Lilly seems a better long-term bet. Pfizer could surprise everyone from an undervalued position.
Wells Fargo reported a solid performance in the second quarter of 2024, with a net income of $4.9 billion and total revenue of $20.689 billion.
BNY's second-quarter results surpassed market expectations, with an EPS of $1.52 and total revenue of $4.6 billion, driven by fee revenue growth and effective expense management.